HCW Biologics Inc (HCWB): Next-Year EPS Estimate 42.71%
As of 2026-05-28, HCW Biologics Inc (HCWB) has a next-year EPS growth estimate of 42.71%.
On 2026-04-01, analyst consensus for HCWB's next-year EPS growth shifted from 81.64% to 42.71% — a negative change of 38.93 percentage points. The revised estimate has been sustained across 48 subsequent trading sessions. Current-year growth is projected at 90.97%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 42.71%
- EPS growth this year
- 90.97%
- EPS next quarter (est)
- -$0.20
- Last price
- $2.09
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 42.71% | 90.97% | -$0.20 | $2.09 |
| 2026-05-27 | 42.71% | 90.97% | -$0.20 | $1.94 |
| 2026-05-26 | 42.71% | 90.97% | -$0.20 | $2.62 |
| 2026-05-25 | 42.71% | 90.97% | -$0.20 | $2.89 |
| 2026-05-24 | 42.71% | 90.97% | -$0.20 | $2.89 |
| 2026-05-21 | 42.71% | 90.97% | -$0.20 | $2.58 |
| 2026-05-20 | 42.71% | 90.97% | -$0.20 | $2.43 |
| 2026-05-19 | 42.71% | 90.97% | -$0.20 | $1.06 |
| 2026-05-18 | 42.71% | 90.97% | -$0.20 | $1.34 |
| 2026-05-17 | 42.71% | 90.97% | -$0.20 | $1.22 |
| 2026-05-14 | 42.71% | 90.97% | -$0.44 | $0.34 |
| 2026-05-13 | 42.71% | 90.97% | -$0.44 | $0.35 |
| 2026-05-12 | 42.71% | 90.97% | -$0.44 | $0.34 |
| 2026-05-11 | 42.71% | 90.97% | -$0.44 | $0.31 |
| 2026-05-10 | 42.71% | 90.97% | -$0.44 | $0.33 |
| 2026-05-07 | 42.71% | 90.97% | -$0.44 | $0.32 |
| 2026-05-06 | 42.71% | 90.97% | -$0.44 | $0.35 |
| 2026-05-05 | 42.71% | 90.97% | -$0.44 | $0.41 |
| 2026-05-04 | 42.71% | 90.97% | -$0.44 | $0.41 |
| 2026-05-03 | 42.71% | 90.97% | -$0.44 | $0.45 |
| 2026-04-30 | 42.71% | 90.97% | -$0.44 | $0.47 |
| 2026-04-29 | 42.71% | 90.97% | -$0.44 | $0.41 |
| 2026-04-28 | 42.71% | 90.97% | -$0.44 | $0.40 |
| 2026-04-27 | 42.71% | 90.97% | -$0.44 | $0.44 |
| 2026-04-26 | 42.71% | 90.97% | -$0.44 | $0.38 |
| 2026-04-24 | 42.71% | 90.97% | -$0.44 | $0.38 |
| 2026-04-23 | 42.71% | 90.97% | -$0.44 | $0.41 |
| 2026-04-22 | 42.71% | 90.97% | -$0.44 | $0.40 |
| 2026-04-21 | 42.71% | 90.97% | -$0.44 | $0.38 |
| 2026-04-20 | 42.71% | 90.97% | -$0.44 | $0.41 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is HCW Biologics Inc's next-year EPS growth estimate?▾
As of 2026-05-28, HCW Biologics Inc (HCWB) has a next-year EPS growth estimate of 42.71%, based on analyst consensus.
When was the latest EPS estimate revision for HCWB?▾
The most recent revision occurred on 2026-04-01, when analysts adjusted the next-year EPS growth estimate from 81.64% to 42.71%.
What sector and industry does HCW Biologics Inc belong to?▾
HCW Biologics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HCWB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. HCW Biologics Inc (HCWB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports